Authors:
G.-Y. Jin, Y. C. Lee, Y. H. Choi, Y. M. Han; Jeon-ju/KP
DOI:
10.1594/ecr2008/C-253
Conclusions
In conclusion, RFA or PTC were promising therapeutic methods for pulmonary malignant tumors with satisfactory outcomes of tumor destruction, especially the tumors with less than or equal to 3.0 cm in diameter. Although the data should be collected more for the patients with inoperable lung malignancy after PCT, PCT might be safer than RFA.